US FDA Approves RapiblykTM for Atrial Fibrillation and Flutter
27 Nov 2024 //
BUSINESSWIRE
Eagle Pharma Submits NDA to U.S. FDA for Landiolol
01 Jun 2022 //
GLOBENEWSWIRE
Eagle Pharma on Track to Support Submission of NDA in Q2 2022 for Landiolol
31 Jan 2022 //
BUSINESSWIRE